Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL161472

O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F.[Ni+2]

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA7 P43166 1/20 0.44
CA13 Q8N1Q1 1/20 0.44
GPR3 P46089 2/20 0.42
ACHE P22303 2/20 0.33
KCNH2 Q12809 6/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
TSHR P16473 1/20 0.31
KMT2A Q03164 1/20 0.31
F2 P00734 1/20 0.30
PRSS1 P07477 1/20 0.30
PRSS2 P07478 1/20 0.30
PRSS3 P35030 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL2461553 1.00 CA1 (0.44) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL28079246 0.96 CA1 (0.41) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL5694899 0.96 CA1 (0.41) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL25287606 0.92 CA1 (0.44) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL25292878 0.92 CA1 (0.44) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL25285896 0.92 CA1 (0.44) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL25292546 0.92 GPR3 (0.48) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL20570425 0.92
Trifluoromethanesulfonic Acid SCHEMBL4367100 0.92 CA1 (0.44) CA1CA2CA7CA13GPR3
Trifluoromethanesulfonic Acid SCHEMBL1172297 0.92 CA1 (0.44) CA1CA2CA7CA13GPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1266 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117164477-B Synthesis method of 1, n-dinitrile compound SOUTH CHINA UNIVERSITY OF TECHNOLOGY (CN) 2026-05-26 CN claimed
CN-122079748-A Guaazulene triarylmethane, synthesis method and application thereof in preparation of antibacterial products 2026-05-26 CN claimed
CN-122079825-A Synthesis method of nickel amidinate complex promoted by triflate 2026-05-26 CN claimed
CN-122079895-A Process for preparing N, S-acetal compounds based on transition metal catalytic systems 2026-05-26 CN claimed
CN-122059983-A Reductive silanization method of nickel-catalyzed alpha-benzoylalkyl bromide and chlorosilane on activated olefin 大连理工大学 2026-05-19 CN claimed
CN-119680546-B Metal catalyst and preparation method and application thereof 中国科学院宁波材料技术与工程研究所 2026-05-12 CN claimed
CN-122010655-A Chiral spiro lactam and synthesis method thereof 上海师范大学 2026-05-12 CN claimed
EP-4685126-A1 PROCESS FOR THE PREPARATION OF C9-ALDEHYDES OR ALDEHYDES. C9 ALCOHOLS FROM BUTENE-CONTAINING HYDROCARBON STREAMS Evonik Oxeno GmbH & Co. KG (DE) 2026-01-28 EP claimed
US-20260022012-A1 METHOD FOR CATALYTICALLY DRY REFORMING METHANE KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2026-01-22 US claimed
US-20250353741-A1 HYDROGEN PRODUCTION BY STEAM REFORMING OF DODECANE USING NICKEL-RED MUD CATALYST KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2025-11-20 US claimed
WO-2004096764-A1 METHOD OF PREPARING A RING COMPOUND HAVING TWO ADJACENT CHIRAL CENTERS ICOS CORPORATION (US) 2004-11-11 WO claimed
US-6329536-B1 REACTING UNSATURATED NITROOLEFIN COMPOUND WITH BETA-DICARBONYL COMPOUND IN THE PRESENCE OF A CATALYST COMPLEX AND A BASE, CATALYST COMPLEX COMPRISING A LIGAND AND A METAL COMPLEX ABBOTT LABORATORIES 2001-12-11 US claimed
EP-1114022-A1 PROCESS FOR PRODUCING STEREOSELECTIVE NITRO COMPOUNDS ABBOTT LABORATORIES (US) 2001-07-11 EP claimed
WO-2000015599-A1 PROCESS FOR PRODUCING STEREOSELECTIVE NITRO COMPOUNDS ABBOTT LABORATORIES (US) 2000-03-23 WO claimed
US-5840785-A DEBINDING REACTION INJECTION MOLDING REACTION WITH METAL POWDERS AND IMPROVED RHEOLOGY MEGAMET INDUSTRIES (US) 1998-11-24 US claimed
WO-1997037789-A1 MOLDING PROCESS FEEDSTOCK USING A COPPER TRIFLATE CATALYST MEGAMET INDUSTRIES (US) 1997-10-16 WO claimed
EP-0490452-B1 Catalyst compositions and process for the preparation of polymers SHELL INT RESEARCH (NL) 1996-09-11 EP claimed
US-5420236-A Catalytic polymerization of ethylene with carbon monoxide SHELL OIL COMPANY (US) 1995-05-30 US claimed
CN-1062355-A Catalyst composition and the method for preparing polymkeric substance SHELL INT RESEARCH (NL) 1992-07-01 CN claimed
EP-0490452-A2 Catalyst compositions and process for the preparation of polymers SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1992-06-17 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260022012-A1 METHOD FOR CATALYTICALLY DRY REFORMING METHANE RNF4, SOD1, HRH4 CA1 315/4885CA2 225/4885CA7 1110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.